The 20 Best Fibrolamellar Carcinoma Doctors Near Me

Dr. Mark Yarchoan is a physician–scientist based in Baltimore who specializes in the treatment and study of gastrointestinal cancers, with a particular focus on liver malignancies, including hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA). He received his undergraduate degree from Amherst College and his medical degree from the Perelman School of Medicine at the University of Pennsylvania. He completed his residency in internal medicine at the Hospital of the University of Pennsylvania, followed by a fellowship in medical oncology at the Johns Hopkins University School of Medicine, where he joined the faculty in 2018. Dr. Yarchoan leads a research laboratory dedicated to developing novel immunotherapies for liver cancers. His translational research program integrates analyses of clinical trial biospecimens with preclinical modeling to identify and overcome barriers to effective antitumor immunity. A major focus of his work is the development of therapeutic cancer vaccines for hepatobiliary malignancies. He serves as Principal Investigator on multiple clinical trials for hepatobiliary cancers, contributes to international guideline committees for liver cancer, and is a member of the Johns Hopkins Graduate Training Programs in Cellular and Molecular Medicine and Immunology. Dr. Yarchoan’s contributions have been recognized with numerous honors, including the ASCO Young Investigator Award, the Conquer Cancer Foundation Career Development Award, the Mark R. Clements Award from the Cholangiocarcinoma Foundation, and the Blue Faery Award for Excellence in Liver Cancer Research. Dr. Yarchoan is rated as an Elite provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, Pancreatic Cancer, and Hepatectomy.

Marina Baretti, MD, is an assistant professor at Johns Hopkins University School of Medicine and the Jiasheng Chair in Hepato-Biliary Cancer Research. She also serves as Co-Director of the Liver and Biliary Cancer Multidisciplinary Clinic at the Sidney Kimmel Comprehensive Cancer Center (SKCCC). Dr. Baretti received her medical degree from the University of Pisa in Italy. She completed her internal medicine residency and oncology fellowship at University of Milan. She then went on and completed her Postdoctoral and Medical Oncology Fellowship at Johns Hopkins University, Baltimore, Maryland. She is deeply engaged in bridging the gap between laboratory discoveries and clinical application, working closely with laboratory-based scientists to accelerate the development of novel therapeutic strategies. Her academic research is centered on the development of novel agents in hepatobiliary cancers, with particular interest in combinatorial approaches of immunotherapies. She is currently the principal investigator on multiple clinical trials in FLC, HCC and cholangiocarcinoma at Johns Hopkins University, collaborating closely with laboratory-based researchers to move laboratory findings into patients. Through her work, Dr. Baretti strives to improve outcomes for patients with rare GI cancers by identifying innovative therapies that are informed by a deeper understanding of tumor biology and the tumor microenvironment. Dr. Baretti was the recipient of the 2018 American Society of Clinical Oncology Young Investigator Award. Dr. Baretti was also awarded with the 2020 Career Development Award for the MD Anderson Cancer Center’s pancreatic cancer NCI Specialized Programs of Research Excellence (SPORE). Dr. Baretti is rated as an Elite provider by MediFind in the treatment of Fibrolamellar Carcinoma. Her top areas of expertise are Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, and Pancreatic Cancer.

. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Fibrolamellar Carcinoma, Familial Pancreatic Cancer, Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection.

. Dr. Nadolski is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Chylous Ascites, Kimura Disease, Fibrolamellar Carcinoma, Liver Embolization, and Gastrostomy.

Dr. John Gordan is a gastrointestinal cancer specialist who cares for patients with hepatobiliary cancers, such as cholangiocarcinoma (bile duct cancer), hepatocellular carcinoma (the most common liver cancer) and gallbladder cancer. Gordan is actively involved in designing and carrying out clinical trials of potential treatments for hepatocellular carcinoma and cholangiocarcinoma. His laboratory research focuses on identifying new therapies for patients with these cancers as well as identifying predictive biomarkers to better apply existing therapies. Gordan completed his medical degree at the University of Pennsylvania, followed by a residency in internal medicine and a fellowship in medical oncology at UCSF. He joined the UCSF faculty in 2015. Gordan is a member of the American Society of Clinical Oncology, which supports his research, as does the American Cancer Society. Dr. Gordan is rated as an Elite provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Adenocarcinoma, Gallbladder Cancer, and Tissue Biopsy.

. Dr. Chakraborty is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), Angiosarcoma, and Bone Marrow Aspiration.

. Dr. Riera is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Hepatitis, Visceromegaly, Hepatitis C, Enlarged Liver, and Liver Embolization.

. Dr. Feyssa is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Hepatitis, Hepatitis C, Visceromegaly, Liver Transplant, and Endoscopy.

Matthew Howenstein is an Interventional Radiologist in Grafton, Wisconsin. Dr. Howenstein is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Visceromegaly, Thyroid Nodule, Lung Nodules, Bone Marrow Aspiration, and Bone Graft.

Edward James is a Hematologist and an Oncologist in Park Ridge, Illinois. Dr. James is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, and Gastrostomy.

. Dr. Stark is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Ascites, Lymphofollicular Hyperplasia, Peripheral Artery Disease, Bone Marrow Aspiration, and Liver Embolization.

Ghassan Abou is an Oncologist in New York, New York. Dr. Abou is rated as an Elite provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Liver Cancer, Cholangiocarcinoma (Bile Duct Cancer), Fibrolamellar Carcinoma, Liver Embolization, and Pancreaticoduodenectomy. Dr. Abou is currently accepting new patients.

Ahmed Kaseb is an Oncologist in Houston, Texas. Dr. Kaseb is rated as an Elite provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Liver Cancer, Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Hepatectomy, and Liver Embolization.

Raymond Yeung is a Surgical Oncologist and a General Surgeon in Seattle, Washington. Dr. Yeung is rated as an Elite provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Fibrolamellar Carcinoma, Liver Cancer, Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Cancer, and Hepatectomy. Dr. Yeung is currently accepting new patients.

Gadi Lalazar is a Gastroenterologist in New York, New York. Dr. Lalazar is rated as an Elite provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Fibrolamellar Carcinoma, Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH), and Liver Cancer.

Erik Schadde is a Transplant Surgeon in Madison, Wisconsin. Dr. Schadde is rated as an Elite provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Fibrolamellar Carcinoma, Liver Cancer, Enlarged Liver, Hepatectomy, and Liver Embolization. Dr. Schadde is currently accepting new patients.

Jordan Tasse is an Interventional Radiologist in Chicago, Illinois. Dr. Tasse is rated as an Elite provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Fibrolamellar Carcinoma, Varicose Veins, Familial Pancreatic Cancer, Liver Embolization, and Angioplasty.

Annika Nelde practices in Tuebingen, Germany. Ms. Nelde is rated as an Elite expert by MediFind in the treatment of Fibrolamellar Carcinoma. Her top areas of expertise are Fibrolamellar Carcinoma, Leukemia, Chronic Lymphocytic Leukemia (CLL), and Chronic B-Cell Leukemia (CBCL).

Yacine Maringer practices in Tuebingen, Germany. Maringer is rated as an Elite expert by MediFind in the treatment of Fibrolamellar Carcinoma. Their top areas of expertise are Fibrolamellar Carcinoma, Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), and Leukemia.

Michael Bitzer practices in Tuebingen, Germany. Mr. Bitzer is rated as an Elite expert by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Fibrolamellar Carcinoma, Liver Cancer, Cholangiocarcinoma (Bile Duct Cancer), and COVID-19.